Advertisement

Pathology & Oncology Research

, Volume 14, Issue 1, pp 69–77 | Cite as

Early Diagnosis of Chemotherapy-induced Cardiomyopathy: a Prospective Tissue Doppler Imaging Study

  • András Csaba NagyEmail author
  • Zsuzsanna Cserép
  • Edina Tolnay
  • Tamás Nagykálnai
  • Tamás Forster
Original Paper

Abstract

The aim of our study was to compare the applicability of the conventional echocardiography and a novel method, tissue Doppler imaging (TDI) in detection of late or subclinical cardiotoxicity following anthracycline chemotherapy in long-term follow up. Forty women (31 to 65 years) were enrolled, who had not received anthracyclines previously and had normal cardiac function. The control group consisted of 20 healthy persons of similar age range. In addition to standard echocardiographic measurements, each patient underwent specific measurements (E-septum separation, pulmonary venous flow) as well. Furthermore, the myocardial velocity of numerous segments of the mitral anulus obtained with pulsed wave TDI was also detected over a two-year-long period. Systolic left ventricular function did not change significantly either in the study or in the control group. After one year, diastolic left ventricular function was impaired in 39 patients (97.5%), and 29 (72.5%) of these showed clear changes by means of the traditional E/A ratio and TDI. However, in ten patients (25%) the diastolic dysfunction could only be detected with TDI. At the end of the study diastolic dysfunction was detected in each patient, but in 13 patients (32.5%) the relaxation disorder could be revealed only with TDI. Detectable myocardial damage occurred in the study group as a result of anthracycline therapy. Our results confirmed our assumptions that TDI is a more precise and useful examination method than the traditional ones (E/A ratio or deceleration time) to demonstrate isolated diastolic dysfunction. TDI may become a regularly and more widely used noninvasive method to detect subclinical cardiotoxicity emerging after chemotherapy.

Keywords

Anthracycline Tissue Doppler imaging Cardiotoxicity 

Abbreviations

AC

doxorubicin and cyclophosphamide

EC

epirubicin and cyclophosphamide

ECG

electrocardiography

EF

ejection fraction

IVSs and IVSd

thicknesses of the left ventricular septum in systole and in diastole

LVPWs and LVPWd

thicknesses of the left ventricular posterior wall in systole and in diastole

LVEDs and LVEDd

left ventricular end-diastolic dimension in systole and in diastole

TDI

tissue Doppler imaging

References

  1. 1.
    Alam M, Wardell J, Andersson E, Samad BA, Nordlander R (2000) Effects of first myocardial infarction on left ventricular systolic and diastolic function with the use of mitral annular velocity determined by pulsed wave Doppler tissue imaging. J Am Soc Echocardiogr 13:343–352PubMedGoogle Scholar
  2. 2.
    Aranda JM Jr, Weston MW, Puleo JA, Fontanet HL (1998) Effect of loading conditions on myocardial relaxation velocities determined by Doppler tissue imaging in heart transplant recipients. J Heart Lung Transplant 17:693–697PubMedGoogle Scholar
  3. 3.
    Billingham ME (1984) Evaluation of anthracycline cardiotoxicity: predictive ability and functional correlation of endomyocardial biopsy. Cancer Treat Symp 3:71–76Google Scholar
  4. 4.
    Bu’Lock FA, Mott MG, Oakhill A, Martin RP (1995) Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology. Br Heart J 73:340–350PubMedCrossRefGoogle Scholar
  5. 5.
    Burstein H, Winer E (2000) Primary care for survivors of breast cancer. N Engl J Med 343:1086–1094PubMedCrossRefGoogle Scholar
  6. 6.
    Canal P, Gamelin E, Vassal G, Robert J (1998) Benefits of pharmacological knowledge in the design and monitoring of cancer chemotherapy. Pathol Oncol Res 4:171–178PubMedCrossRefGoogle Scholar
  7. 7.
    Dandel M, Hummel M, Muller J, Wellnhofer E, Meyer R, Solowjowa N, Ewert R, Hetzer R (2001) Reliability of tissue Doppler wall motion monitoring after heart transplantation for replacement of invasive routine screenings by optimally timed cardiac biopsies and catheterizations. Circulation 104(Suppl 1):I184–I191PubMedGoogle Scholar
  8. 8.
    Kantrowitz NE, Bristow MR (1984) Cardiotoxicity of antitumor agents. Prog Cardiovasc Dis 27:195–200PubMedCrossRefGoogle Scholar
  9. 9.
    Kapusta L, Thijssen JM, Groot-Loonen J, Antonius T, Mulder J, Daniels O (2000) Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines. Ultrasound Med Biol 26:1099–1108PubMedCrossRefGoogle Scholar
  10. 10.
    Kapusta L, Thijssen JM, Groot-Loonen J, van Druten JA, Daniels O (2001) Discriminative ability of conventional echocardiography and tissue Doppler imaging techniques for the detection of subclinical cardiotoxic effects of treatment with anthracyclines. Ultrasound Med Biol 27:1605–1614PubMedCrossRefGoogle Scholar
  11. 11.
    Klein AL, Burstow DJ, Tajik AJ, Zachariah PK, Bailey KR, Seward JB (1994) Effects of Age on left ventricular dimensions and filling dynamics in 117 normal persons. Mayo Clin Proc 69:212–224PubMedGoogle Scholar
  12. 12.
    Krischer JP, Epstein S, Cuthbertson DD, Goorin AM, Epstein ML, Lipshultz SE (1997) Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol 15:1544–1552PubMedGoogle Scholar
  13. 13.
    Krupicka J, Markova J, Pohlreich D, Kozak T, Linkova H, Diehl V (2002) German Hodgkin's Lymphoma Study Group. Echocardiographic evaluation of acute cardiotoxicity in the treatment of Hodgkin disease according to the German Hodgkin's Lymphoma Study Group. Leuk Lymphoma 43:2325–2329PubMedCrossRefGoogle Scholar
  14. 14.
    Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA (1973) A clinico-pathologic analysis of adriamycin cardiotoxicity. Cancer 32:302–314PubMedCrossRefGoogle Scholar
  15. 15.
    Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP (1991) Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Eng J Med 324:808–815CrossRefGoogle Scholar
  16. 16.
    Lipshultz SE, Colan SD, Walsh EP, Sanders SP, Sallan SP (1990) Ventricular tachycardia and sudden unexplained death in late survivors of childhood malignancy treated with doxorubicin. Pediatr Res 27:145AGoogle Scholar
  17. 17.
    Lipshultz SE, Lipsitz SR, Mone SM, Goorin AM, Sallan SE, Sanders SP, Orav EJ, Gelber RD, Colan SD (1995) Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Eng J Med 333:1359–1360CrossRefGoogle Scholar
  18. 18.
    Nagueh SF, Mikati I, Kopelen HA, Middleton KJ, Quinones MA, Zoghbi WA (1998) Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue doppler imaging. Circulation 98:1644–1650PubMedGoogle Scholar
  19. 19.
    Nagy AC, Tolnay E, Nagykalnai T, Forster T (2006) Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI. Neoplasma 53:511–517PubMedGoogle Scholar
  20. 20.
    Nakayama K, Miyatake K, Uematsu M, Tanaka N, Kamakura S, Nakatani S, Yamazaki N, Yamagishi M (1998) Application of tissue Doppler imaging technique in evaluating early ventricular contraction associated with accessory atrioventricular pathways in Wolff–Parkinson–White syndrome. Am Heart J 135:99–106PubMedCrossRefGoogle Scholar
  21. 21.
    Nysom K, Colan SD, Lipshultz SR (1998) Late cardiotoxicity following anthracycline therapy for childhood cancer. Prog Pediatr Cardiol 8:121–128CrossRefGoogle Scholar
  22. 22.
    Pela G, Bruschi G, Cavatorta A, Manca C, Cabassi A, Borghetti A (2001) Doppler tissue echocardiography: myocardial wall motion velocities in essential hypertension. Eur J Echocardiogr 2:108–117PubMedCrossRefGoogle Scholar
  23. 23.
    Rakowski H, Appleton C, Chan KL, Dumesnil JG, Honos G, Jue J, Koilpillai C, Lepage S, Martin RP, Mercier LA, O’Kelly B, Prieur T, Sanfilippo A, Sasson Z, Alvarez N, Pruitt R, Thompson C, Tomlinson C (1996) Canadian consensus recommendation for the measurement and reporting of diastolic dysfunction by echocardiography. J Am Soc Echocardiol 9:736–760CrossRefGoogle Scholar
  24. 24.
    Shimizu Y, Uematsu M, Shimizu H, Nakamura K, Yamagishi M, Miyatake K (1998) Peak negative myocardial velocity gradient in early diastole as a noninvasive indicator of left ventricular diastolic function: comparison with transmitral flow velocity indices. J Am Coll Cardiol 32:1418–1425PubMedCrossRefGoogle Scholar
  25. 25.
    Sogaard P, Hassager C (2004) Tissue Doppler imaging as a guide to resynchronization therapy in patients with congestive heart failure. Curr Opin Cardiol 19:447–451PubMedCrossRefGoogle Scholar
  26. 26.
    Steinberg JS, Cohen AJ, Wasserman AG, Cohen P, Ross AM (1987) Acute arrhythmogenicity of doxorubicin administration. Cancer 60:1213–1218PubMedCrossRefGoogle Scholar
  27. 27.
    Steinherz LJ, Steinherz PG, Tan C (1995) Cardiac failure and dysrhythmias 6–19 years after anthracycline therapy: a series of 15 patients. Med Pediatr Oncol 24:352–361PubMedCrossRefGoogle Scholar
  28. 28.
    Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML (1991) Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 266:1672–1677PubMedCrossRefGoogle Scholar
  29. 29.
    Tabata T, Oki T, Yamada H, Abe M, Onose Y, Thomas JD (2000) Subendocardial motion in hypertrophic cardiomyopathy: assessment from long- and short-axis views by pulsed tissue Doppler imaging. J Am Soc Echocardiogr 13:108–115PubMedGoogle Scholar
  30. 30.
    Tan C, Tasaka H, Yu KP, Murphy ML, Karnofsky DA (1967) Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease: clinical evaluation with special reference to childhood leukemia. Cancer 20:333–353PubMedCrossRefGoogle Scholar
  31. 31.
    Tassan-Mangina S, Codorean D, Metivier M, Costa B, Himberlin C, Jouannaud C, Blaise AM, Elaerts J, Nazeyrollas P (2006) Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study. Eur J Echocardiogr 7:141–146PubMedCrossRefGoogle Scholar
  32. 32.
    Uematsu M, Nakatani S, Yamagishi M, Matsuda H, Miyatake K (1997) Usefulness of myocardial velocity gradient derived from two-dimensional tissue Doppler imaging as an indicator of regional myocardial contraction independent of translational motion assessed in atrial septal defect. Am J Cardiol 79:237–241PubMedCrossRefGoogle Scholar

Copyright information

© Arányi Lajos Foundation 2008

Authors and Affiliations

  • András Csaba Nagy
    • 1
    Email author
  • Zsuzsanna Cserép
    • 2
  • Edina Tolnay
    • 3
  • Tamás Nagykálnai
    • 4
  • Tamás Forster
    • 5
  1. 1.1st Department of Internal Medicine and CardiologyUzsoki Municipal HospitalBudapestHungary
  2. 2.Semmelweis UniversityBudapestHungary
  3. 3.2nd DepartmentPest County Institute of PulmonologyTörökbálintHungary
  4. 4.Oncoradiological CentreUzsoki Municipal HospitalBudapestHungary
  5. 5.2nd Department of Internal Medicine and Cardiological Centre, Albert Szent-Györgyi Medical and Pharmaceutical Centre, Faculty of MedicineUniversity of SzegedSzegedHungary

Personalised recommendations